Author Correction: Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation (Nature Medicine, (2019), 25, 4, (667-678), 10.1038/s41591-019-0405-7);Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation

Nature Medicine

Volumn 25, Issue 4, 2019, Pages 667-678

  Thomas, Andrew Maltez ^a,b,c   Manghi, Paolo ^a   Asnicar, Francesco ^a   Pasolli, Edoardo ^a   Armanini, Federica ^a   Zolfo, Moreno ^a   Beghini, Francesco ^a   Manara, Serena ^a   Karcher, Nicolai ^a   Pozzi, Chiara ^d   Gandini, Sara ^d   Serrano, Davide ^d   Tarallo, Sonia ^e   Francavilla, Antonio ^e   Gallo, Gaetano ^f,g   Trompetto, Mario ^g   Ferrero, Giulio ^h   Mizutani, Sayaka ^i,j   Shiroma, Hirotsugu ⁱ   Shiba, Satoshi ^k   Shibata, Tatsuhiro ^k,l   Yachida, Shinichi ^k,m   Yamada, Takuji ^i,n   Wirbel, Jakob ^o   Schrotz King, Petra ^p   Ulrich, Cornelia M ^q   Brenner, Hermann ^p   Arumugam, Manimozhiyan ^r,s   Bork, Peer ^o,t,u,v   Zeller, Georg ^o   Cordero, Francesca ^h   Dias Neto, Emmanuel ^b,c   Setubal, João Carlos ^b,w   Tett, Adrian ^a   Pardini, Barbara ^e,x   Rescigno, Maria ^y   Waldron, Levi ^z   Naccarati, Alessio ^e,aa   Segata, Nicola ^a   more..

^a UNIVERSITY OF TRENTO   (Italy)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e IIGM Italian Institute for Genomic Medicine   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^g S Rita Hospital   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^j JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^k NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^l UNIVERSITY OF TOKYO   (Japan)

^m OSAKA UNIVERSITY   (Japan)

ⁿ JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^o EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY OF UTAH   (United States)

^r Capital Region   (Denmark)

^s UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^t Molecular Medicine Partnership Unit (MMPU)   (Germany)

^u MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^v UNIVERSITY OF WÜRZBURG   (Germany)

^w VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^x UNIVERSITY OF TURIN   (Italy)

^y HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^z CITY UNIVERSITY OF NEW YORK   (United States)

^aa INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; TRIMETHYLAMINE; LYASE; TUMOR MARKER;

ADENOMA; AREA UNDER THE CURVE; ARTICLE; COLORECTAL CANCER; DEGRADATION; FERMENTATION; GASTROINTESTINAL DISEASE; GENE FUNCTION; GENETIC VARIABILITY; GLUCONEOGENESIS; HUMAN; INTESTINE; METAGENOMICS; MICROBIOME; MOUTH CAVITY; NONHUMAN; PRIORITY JOURNAL; COHORT ANALYSIS; COLORECTAL TUMOR; GENETIC DATABASE; GENETICS; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; SPECIES DIFFERENCE;

BIOMARKERS, TUMOR; CHOLINE; COHORT STUDIES; COLORECTAL NEOPLASMS; DATABASES, GENETIC; GASTROINTESTINAL MICROBIOME; HUMANS; LYASES; METAGENOMICS; SPECIES SPECIFICITY;

EID: 85063766431     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/s41591-019-0663-4     Document Type: Erratum

References (81)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386 (2015).
2. Siegel, R., Desantis, C. & Jemal, A. Colorectal cancer statistics, 2014. CA Cancer J. Clin. 64, 104–117 (2014).
3. Frank, C., Sundquist, J., Yu, H., Hemminki, A. & Hemminki, K. Concordant and discordant familial cancer: familial risks, proportions and population impact. Int. J. Cancer 140, 1510–1516 (2017).
4. Foulkes, W. D. Inherited susceptibility to common cancers. N. Engl. J. Med. 359, 2143–2153 (2008).
5. Johnson, C. M. et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24, 1207–1222 (2013).
6. Huxley, R. R. et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer 125, 171–180 (2009).
7. Schmidt, T. S. B., Raes, J. & Bork, P. The human gut microbiome: from association to modulation. Cell 172, 1198–1215 (2018).
8. Thomas, R. M. & Jobin, C. The microbiome and cancer: is the ‘oncobiome’ mirage real? Trends Cancer Res. 1, 24–35 (2015).
9. Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845 (2017).
10. Pasolli, E., Truong, D. T., Malik, F., Waldron, L. & Segata, N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol. 12, e1004977 (2016).
11. Cougnoux, A. et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 63, 1932–1942 (2014).
12. Wu, S. et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016–1022 (2009).
13. Chung, L. et al. Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host Microbe 23, 203–214.e5 (2018).
14. Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012).
15. Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207–215 (2013).
16. Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013).
17. Yu, J. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66, 70–78 (2017).
18. Feng, Q. et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat. Commun. 6, 6528 (2015).
19. Zeller, G. et al. Potential of fecal microbiota for early‐stage detection of colorectal cancer. Mol. Syst. Biol. 10, 766 (2014).
20. Vogtmann, E. et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS One 11, e0155362 (2016).
21. Baxter, N. T., Ruffin, M. T., Rogers, M. A. M. & Schloss, P. D. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med. 8, 37 (2016).
22. Zackular, J. P., Rogers, M. A. M., Ruffin, M. T. 4th & Schloss, P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev. Res. 7, 1112–1121 (2014).
23. Drewes, J. L. et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes 3, 34 (2017).
24. Pollock, J., Glendinning, L., Wisedchanwet, T. & Watson, M. The madness of microbiome: attempting to find consensus ‘best practice’ for 16S microbiome studies. Appl. Environ. Microbiol. 84, e02627–17 (2018).
25. Segata, N. On the road to strain-resolved comparative metagenomics. mSystems 3, e00190–17 (2018).
26. Truong, D. T., Tett, A., Pasolli, E., Huttenhower, C. & Segata, N. Microbial strain-level population structure and genetic diversity from metagenomes. Genome Res. 27, 626–638 (2017).
27. Pasolli, E. et al. Accessible, curated metagenomic data through ExperimentHub. Nat. Methods 14, 1023 (2017).
28. Dai, Z. et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome 6, 70 (2018).
29. Quince, C., Walker, A. W., Simpson, J. T., Loman, N. J. & Segata, N. Shotgun metagenomics, from sampling to analysis. Nat. Biotechnol. 35, 833–844 (2017).
30. Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 10.1038/s41591-019-0406-6 (2019).
31. Hannigan, G. D., Duhaime, M. B., Ruffin, M. T. 4th, Koumpouras, C. C. & Schloss, P. D. Diagnostic potential and interactive dynamics of the colorectal cancer virome. MBio 9, e02248–18 (2018).
32. Thomas, A. M. et al. Tissue-associated bacterial alterations in rectal carcinoma patients revealed by 16S rRNA community profiling. Front. Cell. Infect. Microbiol. 6, 179 (2016).
33. Gao, Z., Guo, B., Gao, R., Zhu, Q. & Qin, H. Microbiota disbiosis is associated with colorectal cancer. Front. Microbiol. 6, 20 (2015).
34. Ahn, J. et al. Human gut microbiome and risk for colorectal cancer. J. Natl Cancer Inst. 105, 1907–1911 (2013).
35. Flemer, B. et al. The oral microbiota in colorectal cancer is distinctive and predictive. Gut 67, 1454–1463 (2017).
36. Brito, I. L. et al. Mobile genes in the human microbiome are structured from global to individual scales. Nature 535, 435–439 (2016).
37. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
38. Bonder, M. J. et al. The effect of host genetics on the gut microbiome. Nat. Genet. 48, 1407 (2016).
39. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
40. Xie, Y.-H. et al. Fecal Clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine 25, 32–40 (2017).
41. Boleij, A., van Gelder, M. M. H. J., Swinkels, D. W. & Tjalsma, H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin. Infect. Dis. 53, 870–878 (2011).
42. Fijan, S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int. J. Environ. Res. Public Health 11, 4745–4767 (2014).
43. Apweiler, R. et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 32, D115–D119 (2004).
44. Gerner, E. W. & Meyskens, F. L. Jr Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4, 781–792 (2004).
45. Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
46. Riester, M. et al. Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples. J. Natl Cancer Inst. 106, dju048 (2014).
47. Kummen, M. et al. Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. United European Gastroenterol. J. 5, 532–541 (2017).
48. Oellgaard, J., Winther, S. A., Hansen, T. S., Rossing, P. & von Scholten, B. J. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer. Curr. Pharm. Des. 23, 3699–3712 (2017).
49. Kalnins, G. et al. Structure and function of CutC choline lyase from human microbiota bacterium Klebsiella pneumoniae. J. Biol. Chem. 290, 21732–21740 (2015).
50. Rath, S., Heidrich, B., Pieper, D. H. & Vital, M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome 5, 54 (2017).
51. Pasolli, E. et al. Extensive unexplored human microbiome diversity revealed by over 150,000 genomes from metagenomes spanning age, geography, and lifestyle. Cell 176, 1–14 (2019).
52. Hothorn, T., Hornik, K., van de Wiel, M. A. & Zeileis, A. A lego system for conditional inference. Am. Stat. 60, 257–263 (2006).
53. Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822–828 (2014).
54. Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
55. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).
56. Integrative HMP (iHMP) Research Network Consortium. The integrative human microbiome project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe 16, 276–289 (2014).
57. Dejea, C. M. et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359, 592–597 (2018).
58. Manichanh, C. et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55, 205–211 (2006).
59. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
60. Bae, S. et al. Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study. Cancer Res. 74, 7442–7452 (2014).
61. Xu, R., Wang, Q. & Li, L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics 16(Suppl 7), S4 (2015).
62. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357 (2012).
63. Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
64. Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962–968 (2018).
65. Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001).
66. Pedregosa, F. et al. Scikit-learn: machine learning in python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
67. Hastie, T, Tibshirani, R. & Friedman, J. The Elements of Statistical Learning Vol. 1 (Springer, 2009).
68. Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663 (2015).
69. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
70. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403–410 (1990).
71. Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014).
72. Segata, N., Börnigen, D., Morgan, X. C. & Huttenhower, C. PhyloPhlAn is a new method for improved phylogenetic and taxonomic placement of microbes. Nat. Commun. 4, 2304 (2013).
73. Kaminski, J. et al. High-specificity targeted functional profiling in microbial communities with ShortBRED. PLoS Comput. Biol. 11, e1004557 (2015).
74. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
75. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
76. Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156–2158 (2011).
77. Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013).
78. Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
79. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
80. Asnicar, F., Weingart, G., Tickle, T. L., Huttenhower, C. & Segata, N. Compact graphical representation of phylogenetic data and metadata with GraPhlAn. PeerJ 3, e1029 (2015).
81. –ΔΔC(T) Method. Methods 25, 402–408 (2001).